Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and Singapore

(2013) Sze Yee Phuah et al.   PLoS One

Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations

(2012) Yael Laitman et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis

(2012) Ava Kwong et al.   PLoS One

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families

(2010) Peter Kang et al.   BREAST CANCER RESEARCH AND TREATMENT

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

(2010) Ramūnas Janavičius   EPMA Journal

A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer

(2009) Ava Kwong et al.   BREAST CANCER RESEARCH AND TREATMENT

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families

(2008) Mateja Krajc et al.   BMC Medical Genetics

Performance ofBRCA1/2Mutation Prediction Models in Asian Americans

(2008) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY